AptarGroup Inc (NYSE: ATR) is a dispensing and drug delivery packaging company that designs and manufactures pumps, aerosol valves, closures, and elastomeric components used to dispense pharmaceutical, beauty, personal care, food, and beverage products. Revenue is transactional, generated by selling dispensing systems and packaging components to pharmaceutical manufacturers, consumer goods companies, and other branded product makers. The company operates three segments: Pharma, Beauty, and Closures. Pharma is the largest segment, representing approximately 46% of net sales and 69% of Adjusted EBITDA excluding non-allocated corporate costs in FY2025. The company operates 57 manufacturing facilities across North America, Europe, Latin America, China, and other Asia/Middle East regions as of the FY2025 10-K filed February 6, 2026. Pharma segment clean-room manufacturing facilities operate in Argentina, China, France, Germany, India, Switzerland, and the United States.
- Revenue model
- Transactional product sales of dispensing pumps, aerosol valves, closures, and elastomeric packaging components. Customers purchase components per unit of production. In certain cases, customers share in research and development expenses for customer-initiated projects. The company also provides drug development acceleration services within the Pharma segment.
- Products and services
- Primary products include dispensing pumps (finger-actuated systems for sprays, liquids, and lotions), aerosol valves (continuous spray and metered dose), dispensing and non-dispensing closures, elastomeric primary packaging components for injectable drugs, nasal drug delivery spray pumps, metered dose inhaler valves, active material science solutions, and digital health solutions. Beauty segment personal care products accounted for approximately 37% of that segment's net sales in FY2025. Closures segment reported net sales of $730.3 million in FY2025.
- Customers and end markets
- Pharmaceutical and healthcare companies (nasal drug delivery, MDI valves, injectable packaging), beauty and personal care brands (lotion pumps, spray pumps, aerosol valves for hair care, skin care, deodorants), home care (disinfectants, air fresheners, insecticides), food (salad dressing, spreads, food protection), and beverage (functional drinks, dairy). The company serves 10 end markets across a global customer base. No single customer concentration figure is disclosed in the excerpts.
- Value-chain role
- Upstream packaging component manufacturer and drug delivery device supplier sitting between raw material suppliers and finished-goods consumer or pharmaceutical brands. Aptar partners with pharmaceutical companies at the molecular development stage of a medication through regulatory approval and eventual market distribution.
- Geographic exposure
- 57 manufacturing facilities globally as of FY2025: France (11), China (10), Latin America (9), North America (9), Rest of Europe/United Kingdom (8), Germany (6), Other Asia/Middle East (4). France and Germany together host 17 facilities. The Closures segment noted currency rates positively impacted net sales by 1% in FY2025, indicating material non-U.S. revenue exposure.
Source: SEC 10-K, filed 2026-02-06
Industry:
Plastics Products, NEC
Peers:
Ball Corp
BERRY GLOBAL GROUP, INC.
Crown Holdings Inc
Greif Inc
Myers Industries Inc
O-i Glass, Inc
Silgan Holdings Inc
TriMas Corp